Ortoma AB (publ) (STO:ORT.B)
7.31
+0.13 (1.81%)
At close: Aug 14, 2026
Ortoma AB Revenue
Ortoma AB had revenue of 10.60M SEK in the quarter ending June 30, 2026, a decrease of -44.71%. This brings the company's revenue in the last twelve months to 34.37M, down -62.00% year-over-year. In the year 2025, Ortoma AB had annual revenue of 67.27M with 7.92% growth.
Revenue (ttm)
34.37M
Revenue Growth
-62.00%
P/S Ratio
10.09
Revenue / Employee
1.88M
Employees
18
Market Cap
342.01M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 67.27M | 4.94M | 7.92% |
| Dec 31, 2024 | 62.33M | -2.18M | -3.38% |
| Dec 31, 2023 | 64.51M | 38.70M | 149.97% |
| Dec 31, 2022 | 25.81M | 4.52M | 21.21% |
| Dec 31, 2021 | 21.29M | 2.67M | 14.32% |
| Dec 31, 2020 | 18.62M | 6.73M | 56.57% |
| Dec 31, 2019 | 11.90M | -334.01K | -2.73% |
| Dec 31, 2018 | 12.23M | -4.53M | -27.04% |
| Dec 31, 2017 | 16.76M | 1.14M | 7.29% |
| Dec 31, 2016 | 15.62M | 6.37M | 68.81% |
| Dec 31, 2015 | 9.25M | 1.54M | 19.95% |
| Dec 31, 2014 | 7.72M | 4.73M | 158.44% |
| Dec 31, 2013 | 2.99M | 899.48K | 43.12% |
| Dec 31, 2012 | 2.09M | 1.76M | 538.71% |
| Dec 31, 2011 | 326.56K | 88.55K | 37.20% |
| Dec 31, 2010 | 238.02K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Mentice AB | 303.13M |
| Bactiguard Holding AB | 206.94M |
| OssDsign AB | 172.55M |
| Senzime AB | 102.73M |
| Integrum AB | 96.14M |
| Promimic AB | 49.86M |
| SciBase Holding AB | 45.88M |
| BrainCool AB | 44.02M |
Ortoma AB News
- 16 days ago - Ortoma AB Quarterly report: Q2 2026 - Filings
- 3 months ago - Ortoma AB Quarterly report: Q1 2026 - Filings
- 6 months ago - Ortoma AB Quarterly report: Q4 2025 - Filings
- 6 months ago - Ortoma AB Annual report: Q4 2025 - Filings
- 10 months ago - Ortoma AB Quarterly report: Q3 2025 - Filings